OSE-CYTOMASK
Live / Registered — Registered (as of 29 Oct 2024)
What this means for you
Registered since 29 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98098906
- Registration number
- 7548048
- Mark type
- Stylized text
- Filed
- 24 Jul 2023
- Published for opposition
- 13 Aug 2024
- Registered
- 29 Oct 2024
- Attorney of record
- Mary Grieco Lee
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
Owner
- OSE Immunotherapeutics, Nantes, FR
- OSE Immunotherapeutics, Nantes, FR
- OSE Immunotherapeutics, Nantes, FR
Prosecution history
- 29 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION
- 24 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jul 2024 — ASSIGNED TO LIE
- 12 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Nov 2023 — NON-FINAL ACTION E-MAILED
- 28 Nov 2023 — NON-FINAL ACTION WRITTEN
- 26 Nov 2023 — ASSIGNED TO EXAMINER
- 22 Aug 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED